Concord Drugs Limited (CONCORD.BO)
INR 30.73
(-1.92%)
INR 30.73
(-1.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 164.48 Million INR | -2.59% |
| 2022 | 168.86 Million INR | 3.03% |
| 2021 | 163.89 Million INR | 26.68% |
| 2020 | 129.37 Million INR | 35.39% |
| 2019 | 95.56 Million INR | -0.89% |
| 2018 | 96.41 Million INR | -28.94% |
| 2017 | 135.68 Million INR | -10.75% |
| 2016 | 152.02 Million INR | -23.81% |
| 2015 | 199.52 Million INR | -5.98% |
| 2014 | 212.22 Million INR | 23.39% |
| 2013 | 171.99 Million INR | 10.49% |
| 2012 | 155.66 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | 993.6 Thousand INR | -99.41% |
| 2023 Q2 | 169.14 Million INR | 16923.05% |
| 2023 Q3 | 4.54 Million INR | -97.32% |
| 2023 Q4 | 164.48 Million INR | 3523.06% |
| 2023 FY | 164.48 Million INR | -2.59% |
| 2022 FY | 168.86 Million INR | 3.03% |
| 2022 Q2 | 172.29 Million INR | 0.0% |
| 2022 Q3 | 3.3 Million INR | -98.08% |
| 2022 Q4 | 168.86 Million INR | 5013.96% |
| 2021 Q2 | 108.46 Million INR | 19096.64% |
| 2021 FY | 163.89 Million INR | 26.68% |
| 2021 Q1 | 565 Thousand INR | -99.56% |
| 2021 Q4 | 163.89 Million INR | 5821.17% |
| 2021 Q3 | 2.76 Million INR | -97.45% |
| 2020 Q2 | 97.67 Million INR | 25589.48% |
| 2020 Q3 | 41.55 Million INR | -57.45% |
| 2020 FY | 129.37 Million INR | 35.39% |
| 2020 Q1 | 380.2 Thousand INR | -99.6% |
| 2020 Q4 | 129.37 Million INR | 211.32% |
| 2019 Q3 | 557 Thousand INR | -99.43% |
| 2019 FY | 95.56 Million INR | -0.89% |
| 2019 Q4 | 95.56 Million INR | 17056.37% |
| 2019 Q1 | 1.84 Million INR | -98.09% |
| 2019 Q2 | 97.97 Million INR | 5201.79% |
| 2018 Q3 | 1.14 Million INR | -99.1% |
| 2018 Q2 | 127 Million INR | 22710.92% |
| 2018 Q1 | 556.78 Thousand INR | -99.59% |
| 2018 FY | 96.41 Million INR | -28.94% |
| 2018 Q4 | 96.67 Million INR | 8350.7% |
| 2017 Q4 | 135.83 Million INR | 16566.87% |
| 2017 Q2 | 190.3 Million INR | 11003.09% |
| 2017 Q1 | 1.71 Million INR | -99.13% |
| 2017 Q3 | 815 Thousand INR | -99.57% |
| 2017 FY | 135.68 Million INR | -10.75% |
| 2016 Q3 | 548.66 Thousand INR | -99.74% |
| 2016 FY | 152.02 Million INR | -23.81% |
| 2016 Q4 | 197.17 Million INR | 35837.54% |
| 2016 Q2 | 209.87 Million INR | 58724.48% |
| 2016 Q1 | 356.78 Thousand INR | -99.82% |
| 2015 Q3 | 862 Thousand INR | -99.52% |
| 2015 Q2 | 178.99 Million INR | 35203.88% |
| 2015 Q1 | 507 Thousand INR | -99.74% |
| 2015 FY | 199.52 Million INR | -5.98% |
| 2015 Q4 | 199.52 Million INR | 23047.13% |
| 2014 Q4 | 192.69 Million INR | 58827.52% |
| 2014 Q2 | 170.71 Million INR | 0.0% |
| 2014 Q3 | 327 Thousand INR | -99.81% |
| 2014 FY | 212.22 Million INR | 23.39% |
| 2013 Q4 | 171.99 Million INR | 0.0% |
| 2013 FY | 171.99 Million INR | 10.49% |
| 2012 Q4 | 155.66 Million INR | 0.0% |
| 2012 FY | 155.66 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| ANG Lifesciences India Limited | 671.01 Million INR | 75.487% |
| Bacil Pharma Limited | 569 Thousand INR | -28808.084% |
| BDH Industries Limited | -164.47 Million INR | 200.01% |
| Beryl Drugs Limited | 48.7 Million INR | -237.7% |
| Cian Healthcare Limited | 544.97 Million INR | 69.817% |
| Chemo Pharma Laboratories Limited | -6.05 Million INR | 2815.203% |
| Deccan Health Care Limited | -7.07 Million INR | 2424.576% |
| DECIPHER LABS LIMITED | -93.13 Million INR | 276.606% |
| Add-Shop E-Retail Limited | 116.24 Million INR | -41.497% |
| Gujarat Terce Laboratories Limited | 37.76 Million INR | -335.566% |
| Gujarat Themis Biosyn Limited | -53.88 Million INR | 405.261% |
| Hindustan Bio Sciences Limited | 25.21 Million INR | -552.381% |
| Ishita Drugs and Industries Limited | -48.09 Million INR | 441.983% |
| Jenburkt Pharmaceuticals Limited | -791.91 Million INR | 120.771% |
| KIMIA BIOSCIENCES LIMITED | 431.72 Million INR | 61.9% |
| Kwality Pharmaceuticals Limited | 921.75 Million INR | 82.155% |
| Makers Laboratories Limited | 172.59 Million INR | 4.695% |
| Medi-Caps Limited | -3.21 Million INR | 5217.828% |
| MedPlus Health Services Limited | 8.67 Billion INR | 98.105% |
| Panchsheel Organics Limited | -157.82 Million INR | 204.224% |
| Parmax Pharma Limited | 51.8 Million INR | -217.482% |
| Parnax Lab Limited | 787.61 Million INR | 79.116% |
| Patidar Buildcon Limited | 25.12 Million INR | -554.649% |
| Phaarmasia Limited | -4.89 Million INR | 3458.934% |
| PRAVEG LIMITED | -434.98 Million INR | 137.814% |
| Sunil Healthcare Limited | 625.4 Million INR | 73.699% |
| Syschem (India) Limited | 3.53 Million INR | -4557.05% |
| Sanjivani Paranteral Limited. | -85.95 Million INR | 291.375% |
| Sastasundar Ventures Limited | -297.24 Million INR | 155.336% |
| SHAMROCK INDUSTRIAL CO.LTD. | -9.31 Million INR | 1866.778% |
| Smruthi Organics Limited | 111.28 Million INR | -47.802% |
| Source Natural Foods and Herbal Supplements Limited | -58.58 Million INR | 380.762% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 84.289% |
| Trident Lifeline Limited | 117.56 Million INR | -39.917% |
| Transchem Limited | -3.16 Million INR | 5300.348% |
| Trinity League India Limited | -12 Thousand INR | 1370825.0% |
| Tyche Industries Limited | -788.94 Million INR | 120.849% |
| Vikram Thermo (India) Limited | 38.62 Million INR | -325.856% |
| Vista Pharmaceuticals Limited | 78.7 Million INR | -108.994% |
| Vivanza Biosciences Limited | 50.02 Million INR | -228.803% |
| Zenith Healthcare Limited | -25.45 Million INR | 746.137% |
| Zenlabs Ethica Limited | 139.54 Million INR | -17.873% |
| Mercury Laboratories Limited | -26.72 Million INR | 715.388% |
| SHELTER PHARMA LIMITED | -44.62 Million INR | 468.607% |
| Vasundhara Rasayans Limited | -76.15 Million INR | 315.995% |
| Bharat Immunologicals & Biologicals Corporation Limited | 689.39 Million INR | 76.14% |
| Roopa Industries Limited | 216.01 Million INR | 23.854% |
| PANJON LTD. | -12.8 Million INR | 1384.252% |
| Pharmaids Pharmaceuticals Limited | 37.28 Million INR | -341.126% |
| TIAAN CONSUMER LIMITED | 13.44 Million INR | -1123.406% |
| Anuh Pharma Limited | -69.8 Million INR | 335.631% |
| Crestchem Limited | -1.45 Million INR | 11443.931% |
| Emmessar Biotech & Nutrition Limited | -60.73 Million INR | 370.841% |
| Sandu Pharmaceuticals Limited | -11.43 Million INR | 1539.081% |
| Fredun Pharmaceuticals Limited | 1.04 Billion INR | 84.245% |
| Trimurthi Limited | -1.17 Million INR | 14060.873% |
| Shukra Pharmaceuticals Limited | -68.26 Million INR | 340.954% |
| Norris Medicines Limited | 214.86 Million INR | 23.445% |
| Veerhealth Care Limited | -2.38 Million INR | 6996.73% |
| Lactose (India) Limited | 373.97 Million INR | 56.016% |
| OXYGENTA PHARMACEUTICAL LIMITE | 571.32 Million INR | 71.21% |
| Ambalal Sarabhai Enterprises Limited | 132.1 Million INR | -24.517% |
| Gennex Laboratories Limited | -552.54 Million INR | 129.769% |
| Denis Chem Lab Limited | -236.28 Million INR | 169.614% |
| Colinz Laboratories Limited | -64.3 Million INR | 355.8% |
| Godavari Drugs Limited | 530.02 Million INR | 68.966% |
| Zenotech Laboratories Limited | -196.85 Million INR | 183.557% |
| Shree Ganesh Remedies Limited | 201.85 Million INR | 18.513% |
| Bharat Parenterals Limited | 1.48 Billion INR | 88.951% |
| Coral Laboratories Limited | -612.82 Million INR | 126.841% |
| Evoq Remedies Limited | 41.14 Million INR | -299.745% |
| Kerala Ayurveda Limited | 447.82 Million INR | 63.27% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 88.21% |
| Natural Capsules Limited | 956.68 Million INR | 82.806% |
| Auro Laboratories Limited | 252.51 Million INR | 34.861% |